CCL2 and endometrial cancer: A multiple-SNP analysis determined A-A haplotypes, for both CCL5 polymorphisms and T-A-A haplotypes in the range of CCL2 and CCL5 SNPs to be associated with an approximately twice higher risk of endometrial cancer (OR 1.84 95% CI 1.21–2.81, and OR 1.71 95% CI 1.10–2.65, respectively, p ≤ 0.050, see Table 6 and Table 7).